
MRTX9768
CAS No. 2629314-68-5
MRTX9768( MRTX-9768 | MRTX9768 )
Catalog No. M28771 CAS No. 2629314-68-5
MRTX-9768 is a synthetic lethal-based inhibitor designed to bind the PRMT5-MTA complex and selectively target MTAP/CDKN2A-deleted tumors.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
5MG | 642 | Get Quote |
![]() ![]() |
10MG | 1017 | Get Quote |
![]() ![]() |
25MG | 1521 | Get Quote |
![]() ![]() |
50MG | 2043 | Get Quote |
![]() ![]() |
100MG | 2673 | Get Quote |
![]() ![]() |
200MG | Get Quote | Get Quote |
![]() ![]() |
500MG | Get Quote | Get Quote |
![]() ![]() |
1G | Get Quote | Get Quote |
![]() ![]() |
Biological Information
-
Product NameMRTX9768
-
NoteResearch use only, not for human use.
-
Brief DescriptionMRTX-9768 is a synthetic lethal-based inhibitor designed to bind the PRMT5-MTA complex and selectively target MTAP/CDKN2A-deleted tumors.
-
DescriptionMRTX-9768 is a synthetic lethal-based inhibitor designed to bind the PRMT5-MTA complex and selectively target MTAP/CDKN2A-deleted tumors.(In Vitro):MRTX-9768, a potent inhibitor of SDMA and cell proliferation in HCT116 MTAP-del cells (SDMA IC50 3 nM; prolif. IC50 11 nM) with marked selectivity over HCT116 MTAP-WT cells (SDMA IC50 544 nM; prolif. IC50 861 nM).(In Vivo):In xenograft studies, oral administration of MRTX-9768 demonstrates dose-dependent inhibition of SDMA in MTAP-del tumors, with less SDMA modulation observed in bone marrow.
-
In Vitro——
-
In Vivo——
-
SynonymsMRTX-9768 | MRTX9768
-
PathwayChromatin/Epigenetic
-
TargetHistone Demethylase
-
RecptorCK2
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2629314-68-5
-
Formula Weight424.43
-
Molecular FormulaC24H17FN6O
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 50 mg/mL (117.81 mM)
-
SMILESFC1=C(C2=C(C3=CC=C(C(NN=C4CN)=O)C4=C3)C=NN2C)C(C#N)=C(C=CC=C5)C5=C1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Golub A G , Bdzhola V G , Briukhovetska N V , et al. Synthesis and biological evaluation of substituted (thieno[2,3-d]pyrimidin-4-ylthio)carboxylic acids as inhibitors of human protein kinase CK2[J]. European Journal of Medicinal Chemistry, 2011, 46(3):870-876.
molnova catalog



related products
-
GSK-2879552
A potent, selective irreversible inhibitor of LSD1 with Ki app of 1.7 uM.
-
CPI-455
A potent, specific histone demethylase pan-KDM5 inhibitor with biochemical IC50 of 10, 3 and 14 nM for KDM5A, KDM5B and KDM5C, respectively.
-
KDM4D-IN-10r
KDM4D-IN-10r is a potent, selective histone lysine demethylase 4D (KDM4D) inhibitor with IC50 of 0.41 uM.